STAT

SEPTEMBER 12, 2024

This calls for celebration with a cup of stimulation, and we are opening a new package of pecan pie for the occasion. In a press release issued ahead of an investor meeting today, the company also said it plans to break even by 2028, when it expects it will reach annual sales of $6 billion. Sound familiar? Have a great day, everyone.

Packaging 139

Packaging Diabetes Vaccines 139

Express Pharma

DECEMBER 11, 2023

The COVID-19 pandemic also highlighted the vital role of the cold chain in ensuring patient safety during vaccine distribution. And, with India’s vaccine, biopharma, and clinical trials market projected to grow in double-digits, there will be an increasing demand for efficient cold chain facilities. per cent during 2022-2028.

Packaging 115

Packaging Vaccines 115

Express Pharma

NOVEMBER 24, 2023

lakh crores) by 2028. Fette Compacting Machinery India, Ace Technologies & Packaging Systems, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare, Venkata Narayana Active Ingredients, Unilab Chemicals and Pharmaceuticals, and many others. billion (Rs 8.5

Packaging 105

Packaging Vaccines Pharmaceutical Manufacturing Hospitals 105

Express Pharma

APRIL 10, 2025

Research has reported that fear of needles constitutes about 20-50 per cent among children and 20-30 per cent among adults globally; often leading to missed vaccinations and delayed treatments. How does the company collaborate with pharma and vaccine companies to optimise efficacy of medicines with this delivery system?

Vaccines 83

Vaccines Hospitals Packaging Dosage 83

European Pharmaceutical Review

NOVEMBER 14, 2023

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105

Packaging Vaccines Documentation 105

PharmaTech

JUNE 12, 2025

While BioNTech is best known for co-developing the first approved mRNA vaccine with Pfizer, the company continues to invest heavily in mRNA research targeting various solid tumors and infectious diseases. billion and an additional $2 billion in non-contingent anniversary payments through 2028. billion for BNT327 (2). References 1.

Dosage 52

Dosage Drug Development Vaccines Packaging 52

PharmaShots

JUNE 1, 2023

PDC*line is much more potent than conventional dendritic cell-based vaccines in priming and boosting antitumor antigen-specific cytotoxic T-cells, including the T-cells specific for neoantigens, and is synergistic with checkpoint inhibitors. These new results reinforce our differentiating data package for PDC*lung01.

Immunization 40

Immunization Immunity Vaccines Health and Personal Care Stores 40